Programmed Innate Leukocytes as Potent Therapeutic Agents to Treat Atherosclerosis and Stroke
This invention discloses a novel strategy to reprogram either allogenic or heterologous peripheral blood neutrophils and/or monocytes with a selective compound in vitro, into a homeostatic state that is conducive for healing of coronary heart disease and/or stroke. Reprogrammed monocytes and/or neutrophils can be used through i.v. injection into human...
Published: 1/31/2024
|
Inventor(s): Liwu Li, Shuo Geng, Yao Zhang
Keywords(s):
Category(s): Technology Classifications > Biomedical
|